CHO-IL2RA Cells
USD$1,900.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | Disclaimer: The prices displayed for cell lines are exclusively for academic/not-for-profit customers. For commercial entitites the price is approximately €6,250. CHO-IL2RA cells are recombinant Chinese hamster ovary (CHO) cells engineered to stably express human interleukin-2 receptor alpha (IL-2Rα; CD25/IL2RA), a high-affinity cytokine receptor subunit involved in regulation of T-cell activation and immune homeostasis. CD25 forms part of the heterotrimeric IL-2 receptor complex together with IL-2Rβ (CD122) and the common gamma chain (CD132), enabling high-affinity binding of interleukin-2 and activation of downstream JAK/STAT signaling pathways. Physiologically, CD25 is highly expressed on activated T lymphocytes and regulatory T cells (Tregs), and aberrant expression has also been reported in several hematologic malignancies and inflammatory disorders. CHO-IL2RA cells are widely used in immunology and therapeutic development workflows for characterization of anti-CD25 monoclonal antibodies, cytokine-based therapeutics, bispecific antibodies, and engineered immune cell targeting strategies. The stable recombinant expression system enables quantitative assessment of ligand binding, receptor occupancy, antibody affinity, and receptor internalization. These cells are also valuable for flow cytometry assay development, potency testing, cell-based binding assays, and high-throughput screening applications involving IL-2 pathway modulation. In addition, CHO-IL2RA models can support studies examining selective targeting of activated T cells or regulatory T-cell-associated mechanisms in autoimmunity, transplantation, and cancer immunotherapy. |
|---|---|
| Organism | Chinese hamster |
| Tissue | Ovary |
| Disease | Chinese hamster ovary, non-neoplastic; genetically engineered for IL2RA (CD25) surface expression |
| Applications | Antibody screening; IL2RA-targeted therapy development; T-cell biology research; autoimmune disease research; flow cytometry |
Characteristics
| Age | Adult |
|---|---|
| Gender | Female |
| Morphology | Epithelial-like |
| Cell type | Epithelial cells |
| Growth properties | Adherent/suspension |
Regulatory Data
| Citation | CHO-IL2RA (Cytion catalog number 305980) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10029 |
| CellosaurusAccession | CVCL_A8W8 |
| GMO Status | GMO-S1: This CHO cell line contains an IL2RA expression cassette supporting receptor-function analyses. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Surface antigens | IL2RA (CD25) |
|---|
Handling
| Culture Medium | For adherent cultures: DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) For suspension cultures: CHO Growth Medium A (from InSCREENeX; InSCREENeX catalog number INS-ME-1039) |
|---|---|
| Supplements | For adherent cultures: Supplement the medium with 5% FBS. Add Geneticin (G418-Sulfat) to achieve a final concentration of 0.5 mg/mL. |
| Dissociation Reagent | For adherent cultures: Trypsin-EDTA |
| Doubling time | approx. 14-16 hours |
| Subculturing | For routine adherent cell culture: Aspirate the old culture medium from the adherent cells, and wash them with PBS to remove any remaining medium. After aspirating the PBS, add the appropriate volume of Trypsin/EDTA solution based on the culture vessel size (e.g., 1 ml for a T25 flask, 3 ml for a T75 flask) and incubate at room temperature or 37°C for 5-10 minutes, or until the cells detach. Monitor detachment under a microscope, and gently tap the vessel if necessary to release the cells. Once detached, add complete medium to inactivate the Trypsin/EDTA, gently resuspend the cells, and transfer an aliquot of the cell suspension into a new culture vessel containing fresh medium. Place the vessel in an incubator set to 37°C with 5% CO2, and change the medium every 2-3 days. |
| Split ratio | 1 to 5 |
| Seeding density | 2 to 5 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, split the cells at a ratio of 1:2 to 1:3 in T25 flasks and allow the cells to recover from the freezing process and to adhere (for adherent cultures) for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|